These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 18727807)

  • 1. Prevalence of emm types 1 and 12 from invasive Streptococcus pyogenes disease in Greece--results of enhanced surveillance.
    Stathi A; Papaparaskevas J; Zachariadou L; Pangalis A; Legakis NJ; Tseleni-Kotsovili A; ; Tassios PT
    Clin Microbiol Infect; 2008 Aug; 14(8):808-12. PubMed ID: 18727807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of emm types among group A streptococcal isolates from Serbia.
    Mijac V; Ranin L; Marković M; Heeg C; Reinert RR; Opavski N
    Clin Microbiol Infect; 2010 Mar; 16(3):295-8. PubMed ID: 19519840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrolide, lincosamide and tetracycline susceptibility and emm characterisation of invasive Streptococcus pyogenes isolates in Israel.
    Nir-Paz R; Block C; Shasha D; Korenman Z; Gorodnitzky Z; Jaffe J; Ron M; Michael-Gayego A; Cohen-Poradosu R; Shapiro M; Moses AE
    Int J Antimicrob Agents; 2006 Oct; 28(4):313-9. PubMed ID: 16973336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Streptococcus pyogenes emm and T types within a decade, 1996-2005: implications for epidemiology and future vaccines.
    Nir-Paz R; Korenman Z; Ron M; Michael-Gayego A; Cohen-Poradosu R; Valinsky L; Beall B; Moses AE
    Epidemiol Infect; 2010 Jan; 138(1):53-60. PubMed ID: 19480723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrolide resistance in Streptococcus pyogenes: prevalence, resistance determinants, and emm types.
    Michos AG; Bakoula CG; Braoudaki M; Koutouzi FI; Roma ES; Pangalis A; Nikolopoulou G; Kirikou E; Syriopoulou VP
    Diagn Microbiol Infect Dis; 2009 Jul; 64(3):295-9. PubMed ID: 19395219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of invasive Streptococcus pyogenes disease in Germany during 2003-2007.
    Imöhl M; Reinert RR; Ocklenburg C; van der Linden M
    FEMS Immunol Med Microbiol; 2010 Apr; 58(3):389-96. PubMed ID: 20146737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decrease of erythromycin resistance in group A streptococci by change of emm distribution.
    Koh EH; Kim S; Lee NY
    Jpn J Infect Dis; 2008 Jul; 61(4):261-3. PubMed ID: 18653965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strain prevalence, rather than innate virulence potential, is the major factor responsible for an increase in serious group A streptococcus infections.
    Rogers S; Commons R; Danchin MH; Selvaraj G; Kelpie L; Curtis N; Robins-Browne R; Carapetis JR
    J Infect Dis; 2007 Jun; 195(11):1625-33. PubMed ID: 17471432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular epidemiology of group A streptococcus causing scarlet fever in northern Taiwan, 2001-2002.
    Chen YY; Huang CT; Yao SM; Chang YC; Shen PW; Chou CY; Li SY
    Diagn Microbiol Infect Dis; 2007 Jul; 58(3):289-95. PubMed ID: 17532590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of emm types and antibiotic resistance of group A streptococci in Austria.
    Eisner A; Leitner E; Feierl G; Kessler HH; Marth E
    Diagn Microbiol Infect Dis; 2006 Aug; 55(4):347-50. PubMed ID: 16725301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological markers of Streptococcus pyogenes strains in Tunisia.
    Hraoui M; Boutiba-Ben Boubaker I; Doloy A; Samir E; Ben Redjeb S; Bouvet A
    Clin Microbiol Infect; 2011 Jan; 17(1):63-8. PubMed ID: 20132259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variations in emm type among group A streptococcal isolates causing invasive or noninvasive infections in a nationwide study.
    Ekelund K; Darenberg J; Norrby-Teglund A; Hoffmann S; Bang D; Skinhøj P; Konradsen HB
    J Clin Microbiol; 2005 Jul; 43(7):3101-9. PubMed ID: 16000420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A family outbreak due to an emm-type 11 multiresistant strain of Streptococcus pyogenes.
    Martinaud C; Doloy A; Graffin B; Gaillard T; Poyet R; Mallet S; Carsuzaa F; Brisou P; Bouvet A
    Clin Microbiol Infect; 2010 Mar; 16(3):292-5. PubMed ID: 19519845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular epidemiology, antimicrobial susceptibilities and resistance mechanisms of Streptococcus pyogenes isolates resistant to erythromycin and tetracycline in Spain (1994-2006).
    Rubio-López V; Valdezate S; Alvarez D; Villalón P; Medina MJ; Salcedo C; Sáez-Nieto JA
    BMC Microbiol; 2012 Sep; 12():215. PubMed ID: 22998619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Characteristics of Erythromycin-Resistant Streptococcus pyogenes Strains Isolated from Children Patients in Tunis, Tunisia.
    Ksia S; Smaoui H; Hraoui M; Bouafsoun A; Boutiba-Ben Boubaker I; Kechrid A
    Microb Drug Resist; 2017 Jul; 23(5):633-639. PubMed ID: 27991848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survey of emm gene sequences from pharyngeal Streptococcus pyogenes isolates collected in Spain and their relationship with erythromycin susceptibility.
    Albertí S; García-Rey C; Domínguez MA; Aguilar L; Cercenado E; Gobernado M; García-Perea A;
    J Clin Microbiol; 2003 Jun; 41(6):2385-90. PubMed ID: 12791853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What causes decreased erythromycin resistance in Streptococcus pyogenes? Dynamics of four clones in a southern European region from 2005 to 2012.
    Montes M; Tamayo E; Mojica C; García-Arenzana JM; Esnal O; Pérez-Trallero E
    J Antimicrob Chemother; 2014 Jun; 69(6):1474-82. PubMed ID: 24562616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrolide and tetracycline resistance and emm type distribution of Streptococcus pyogenes isolates recovered from Turkish patients.
    Dundar D; Sayan M; Tamer GS
    Microb Drug Resist; 2010 Dec; 16(4):279-84. PubMed ID: 20624096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and antibiotic resistance of group A streptococci isolated from healthy schoolchildren in Korea.
    Kim S; Lee NY
    J Antimicrob Chemother; 2004 Aug; 54(2):447-50. PubMed ID: 15269193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular analysis of Streptococcus pyogenes macrolide resistance of paediatric isolates during a 7 year period (2007-13).
    Michos A; Koutouzi FI; Tsakris A; Chatzichristou P; Koutouzis EI; Daikos GL; Stathi A; Syriopoulou VP
    J Antimicrob Chemother; 2016 Aug; 71(8):2113-7. PubMed ID: 27118782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.